Increased intramyocellular lipid content in type 2 diabetes may involve dysregulation of the liver X receptor

被引：0
|
作者：
Hojlund, K
Wensaas, A
Kase, ET
Aas, V
Rustan, AC
Thoresen, GH
Levin, K
Beck-Nielsen, H
Gaster, M
机构：
[1] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark
[2] Univ Oslo, Sch Pharm, Dept Pharmacol, N-0316 Oslo, Norway
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19
引用
收藏
页码：A10 / A10
页数：1
相关论文
共 50 条
  • [1] Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway
    Kase, ET
    Wensaas, AJ
    Aas, V
    Hojlund, K
    Levin, K
    Thoresen, GH
    Beck-Nielsen, H
    Rustan, AC
    Gaster, M
    DIABETES, 2005, 54 (04) : 1108 - 1115
  • [2] Increased Intramyocellular Lipid in Type 2 Diabetes: Dependence upon, Muscle Group
    Bajpeyi, Sudip
    Newcomer, Bradley R.
    Murray, Kori B.
    Neiderhofer, Randy
    Smith, Steven R.
    DIABETES, 2010, 59 : A426 - A426
  • [3] Intramyocellular lipid content in older adults at risk for developing type 2 diabetes
    Dube, John J.
    Amati, Francesca
    Sun, Ming
    Toledo, Frederic G. S.
    Stephanovich, Maja
    Goodpaster, Bret H.
    DIABETES, 2006, 55 : A333 - A333
  • [4] Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes
    De Feyter, Henk M.
    Lenaers, Ellen
    Houten, Sander M.
    Schrauwen, Patrick
    Hesselink, Matthijs K.
    Wanders, Ronald J. A.
    Nicolay, Klaas
    Prompers, Jeanine J.
    FASEB JOURNAL, 2008, 22 (11): : 3947 - 3955
  • [5] Dynamics of intramyocellular lipid content during the initial course of type 1 and type 2 diabetes
    Schoen, M.
    Strassburger, K.
    Kupriyanova, Y.
    Zaharia, O. P.
    Bodis, K.
    Yurchenko, I.
    Moeser, C.
    Huttasch, M.
    Bombrich, M.
    Schrauwen-Hinderling, V.
    Burkart, V.
    Roden, M.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S134 - S135
  • [6] Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes
    Perseghin, G
    Lattuada, G
    Danna, M
    Sereni, LP
    Maffi, P
    De Cobelli, F
    Battezzati, A
    Secchi, A
    Del Maschio, A
    Luzi, L
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 285 (06): : E1174 - E1181
  • [7] Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects
    Jacob, S
    Machann, J
    Rett, K
    Brechtel, K
    Volk, A
    Renn, W
    Maerker, E
    Matthaei, S
    Schick, F
    Claussen, CD
    Häring, HU
    DIABETES, 1999, 48 (05) : 1113 - 1119
  • [8] Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
    Schoen, Martin
    Zaharia, Oana P.
    Strassburger, Klaus
    Kupriyanova, Yuliya
    Bodis, Kalman
    Heilmann, Geronimo
    Strom, Alexander
    Boenhof, Gidon J.
    Michelotti, Filippo
    Yurchenko, Iryna
    Moeser, Clara
    Huttasch, Maximilian
    Bombrich, Maria
    Kelm, Malte
    Burkart, Volker
    Schrauwen-Hinderling, Vera B.
    Wagner, Robert
    Roden, Michael
    DIABETES, 2023, 72 (10) : 1483 - 1492
  • [9] Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes
    van Loon, LJC
    Koopman, R
    Manders, R
    van der Weegen, W
    van Kranenburg, GP
    Keizer, HA
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2004, 287 (03): : E558 - E565
  • [10] Intramyocellular lipid content in Type 2 diabetes patients compared to overweight sedentary controls and highly trained endurance athletes
    Manders, RJF
    Koopman, R
    Zorenc, AHG
    Keizer, HA
    van Loon, LJC
    DIABETOLOGIA, 2004, 47 : A201 - A201
12345